News brief
On 2026/9/23, Presspool reported that US AI drug discovery company Enveda had raised USD 311 million in Series E funding led by Catalio Capital Management.
Connected profiles
Explore
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- presspool.ai ↗Published Sep 23, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年9月23日，据Presspool报道，美国AI药物发现公司Enveda完成3.11亿美元E轮融资，由Catalio Capital Management领投。